Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Playing Through Pain: NFL Gets Yellow Flag For Opioid Misuse
  • USA - English


News provided by

Center for Network Therapy

Mar 31, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Professional athletes are willing to cross the limit in opioid pain medication use for one reason - to be able to continue to perform near-peak despite injuries.

Post this

New York, NY (PRWEB) March 31, 2017 -- As per research* by Washington University, retired National Football League (NFL) players misused opioid pain medications at a rate four times greater than the average. The study provides a rare look into the NFL’s relationship with medications and how team doctors manage the pain in a physically bruising sport to keep players on the field. “Professional football players and athletes have a long life to live after retirement and misuse or abuse of opioid pain medication can have serious long-term consequences, including addiction,” says Dr. Indra Cidambi, Addiction Medicine Expert & Medical Director at the Center for Network Therapy.

Dr. Cidambi believes most professional athletes and football players do not get the complete picture about the medications they are taking in order to make informed decisions. “They need to understand that opioid pain medications are designed to treat acute pain in the short-term and they should be used in conjunction with rehabilitative therapy so that the patient can be switched to non-addictive medications.” Professional athletes need to consider the following:

Opioid Use Does Not Enhance Physical Performance
Professional football players have to realize that using opioid pain medications is more likely to slow a person down than enhance physical capabilities. “Professional athletes are willing to cross the limit in opioid pain medication use for one reason - to be able to continue to perform near-peak despite injuries,” says Dr. Cidambi. Opioids, however, can cause euphoria, decrease anxiety, provide a false sense of invincibility and illusions of athletic prowess beyond their abilities, which may help a player psychologically, but increase the danger of further injuries. When opioid pain medications are used to mask pain in order to continue playing, players may find that they have not given time for their current injuries to heal and have actually made the injury worse.

Long Life to Live After Retirement – Stay Healthy
“Most professional athletes and ball players end their sports careers at an age when others are just getting going in theirs,” notes Dr. Cidambi. “They have a long life to live after they retire from their sport and long-term use or misuse of opioid pain medication has serious consequences.” Dr. Cidambi cautions that long-term (over six months) use of opioid pain medication actually increases one’s sensitivity to pain, requiring higher doses. Continued use also leads to decreased energy and drive, daytime sedation and sleepiness and constipation. Ingesting higher doses over the long-term will likely cause tolerance and dependence, which can lead to brain damage due to respiratory depression (Hypoxia). The risk of overdose is always present.

Retirement is Traumatic – Opioids May Provide Escape
“Professional athletes retire from their sport at a very early age. They usually have not had the time to develop other skills or even hobbies,” says Dr. Cidambi. “So they enter retirement in a vacuum and they also find that the media’s attention has moved on to the emerging star in their sport. They oftentimes suffer from a chronic injury resulting from ignoring rehabilitative treatment and using opioid medications to play through their pain.” Consequently, they face a tremendous trauma in their life at retirement. “In the absence of a strong social support system, it is easy for them to turn to pain pills to mask their feelings and escape from reality, especially if they have misused pain pills during their careers.”

Chronic Opioid Use Will Likely Lead to Addiction
When used over an extended period, opioid pain medications do not work well due to increased tolerance and sensitivity to pain requiring higher doses of medication to achieve a similar effect. Dr. Cidambi notes, “This is a trap many legitimate users of pain medications fall into and they are unable to quit, as their bodies have become chemically dependent to the medication.” This dependence is real and severe, as they face acute withdrawal symptoms (shakes, chills, etc.) when they try to quit or switch to non-narcotic pain medications. “So they keep taking the pain pills in order to be able to feel normal and function.”

Coming Off Opioids Is Not Easy, But Doable
Opioid pain pills can be very addictive – they are made from the same stuff as heroin! Additionally, the fear of facing withdrawal symptoms keeps the user from trying to quit. But detoxification centers can make the process of weaning off of opiates easier by using medication assisted treatment (usually buprenorphine). “Medication alone is not the answer,” cautions Dr. Cidambi. “The person who has become dependent on opioids also needs therapy to effect needed lifestyle changes and find other modalities of care to alleviate the pain.” Yoga, meditation, biofeedback and acupuncture could be introduced to deal with the pain and lead a healthy life.

For more information on opioid abuse and addiction or to learn more about the Center for Network Therapy please visit, http://www.RecoveryCNT.com.

About Dr. Indra Cidambi
Indra Cidambi, M.D., Medical Director, Center for Network Therapy, is recognized as a leading expert and pioneer in the field of Addiction Medicine. Under her leadership the Center for Network Therapy started New Jersey’s first state licensed Ambulatory (Outpatient) Detoxification program for alcohol, benzodiazepines and opiates four years ago. Dr. Cidambi is Board Certified in General Psychiatry and double Board Certified in Addiction Medicine (ABAM, ABPN). She is fluent in five languages, including Russian.

About Center for Network Therapy
Center for Network Therapy (CNT) was the first facility in New Jersey to be licensed to provide Ambulatory (Outpatient) Detoxification Services for all substances of abuse – alcohol, anesthetics, benzodiazepines, opiates and other substances of abuse. Led by a Board Certified Addiction Psychiatrist, Indra Cidambi, M.D., experienced physicians and nurses closely monitor each patient’s progress. With CNT’s superior client care and high quality treatment, Dr. Cidambi and her clinical team have successfully detoxed over 1,000 patients in nearly four years. The Center for Network Therapy also offers step down to Partial Care (PHP and Intensive Outpatient (IOP) levels of care.

  • The study was conducted by researchers at Washington University in St. Louis School of Medicine, and was commissioned by ESPN, with additional funding provided by the National Institute on Drug Abuse, a division of the U.S. Department of Health and Human Services.

**Reference Articles: https://www.washingtonpost.com/sports/redskins/nfl-abuse-of-painkillers-and-other-drugs-described-in-court-filings/2017/03/09/be1a71d8-035a-11e7-ad5b-d22680e18d10_story.html?utm_term=.368d434c42e7
# # #

Jessica Moschella, Center for Network Therapy, +1 212.805.3025, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.